Elon Musk is once again pushing the boundary between science fiction and reality, as Neuralink—the brain–computer interface company he founded—has just announced a new surgical milestone: its robot has inserted an electrode needle into the human brain in just 1.5 seconds, breaking a time barrier long considered a major obstacle to the safety and commercial viability of brain-implant technology.

According to reports by Reuters, this marks a critical technical breakthrough. Previously, inserting each electrode thread—thinner than a human hair—into brain tissue took tens of seconds and required extreme precision to avoid tiny blood vessels.

Neuralink said its new-generation surgical robot uses a high-resolution vision system combined with algorithms that track brain movement in sync with the heartbeat, allowing the implantation needle to “move with the brain tissue” rather than against it. Reducing the insertion time to 1.5 seconds not only lowers the risk of tissue damage but also opens the door to greater automation and scalability of the procedure.

Even more striking is the context in which this announcement comes. According to Elon Musk in conversations with U.S. media, tens of thousands of people have already signed up for Neuralink’s brain-implant trials. Business Insider reports that the waiting list includes not only patients with paralysis, spinal cord injuries, or severe neurological disorders, but also healthy individuals curious about the possibility of “upgrading” humans through technology. Neuralink, however, stresses that surgeries are currently tightly restricted, focused strictly on biomedical goals, with only a few dozen patients implanted so far.

Early trials have already generated significant attention. According to the Financial Times and MIT Technology Review, some implanted patients have been able to control a computer cursor, type text, or play video games using only their thoughts. These results reinforce Musk’s long-term ambition: to turn brain–computer interfaces into a direct bridge between humans and artificial intelligence—and even a potential “defense layer” against a future in which AI surpasses human intelligence.

However, behind the excitement lies a host of unanswered questions.

Citing experts in neuroscience, Reuters notes that while implantation speed has improved dramatically, the greatest challenges remain long-term safety, the ability to remove or upgrade the device, and the protection of neural data—one of the most sensitive forms of personal information. In addition, the fact that tens of thousands of people are willing to sign up to become “cyborgs” has sparked debate over ethics, unequal access to technology, and the risk of commercializing a still-nascent field too early.

Despite the controversies, observers agree that the 1.5-second milestone is more than just a technical figure. It signals that Neuralink is moving closer to turning brain implantation from a complex scientific experiment into a scalable medical procedure. And if Elon Musk’s ambitions are realized, the debate over the boundary between humans and machines—once confined to science fiction—may soon become a very real issue of the 21st century.